Transporters in the kidney are critical in the body's defense against foreign substances including drugs and other xenobiotics. Recently, the first polyspecific (i.e., broadly selective) organic cation transporters (OCT1 and OCT2) were cloned and found to belong to a single gene family, termed OCT. These transporters were cloned from various species including rat (rOCT1, rOCT1A (this laboratory) and rOTC2), rabbit (rbOTC1, this laboratory), and human (hOCT1 (this laboratory) and hOCT2). Although the mRNA transcripts of the OCT transporters are expressed to variable degrees in mammalian kidney, the specific role of OCT1 and OCT2 in renal transport and particularly in the site specific transport of xenobiotics including clinically important drugs has not been established. The primary goal of the proposed research in this continuing application is to understand the fundamental mechanism of organic cation transport in the kidney with particular emphasis on ascertaining the functional roles of OCT1 and OCT2 in renal transport. The studies will focus primarily on mechanisms of transport in the human kidney; however, some studies of the cloned rabbit transporters, rbOCT1 and rbOCT2, will be carried out.
The aims of the proposed studies are to 1. Clone and sequence the organic cation transporter (rbOCT2) in rabbit kidney. 2. Elucidate the functional characteristics of the cloned renal organic cation transporters, OCT1 and OCT2. 3. Determine the mechanisms of transport of model organic cations across the basolateral membrane of the human kidney. 4. Determine the segmental distribution of OCT1 and OCT2 in the nephron and the sorting to the brush border or basolateral membrane. Briefly, the PI will employ PCR based methods to clone the transporters and then perform functional studies in heterologous expression systems. Specifically, the PI will determine the substrate selectivity, saturability and driving forces of the transporters. Parallel studies in isolated basolateral membrane vesicles from human kidney will be carried out to determine the biological relevance of the cloned transporters. Polyclonal antibodies will be used to localize the transporters along the nephron and determine their intracellular sorting. These studies will greatly advance our understanding of the mechanisms involved in organic cation transport in the human kidney as well as our understanding of tissue-specific elimination and toxicities of drugs, environmental toxins and other xenobiotics.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM036780-12A1
Application #
2688127
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Scherbenske, M James
Project Start
1986-04-04
Project End
2002-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chen, Ligong; Shu, Yan; Liang, Xiaomin et al. (2014) OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc Natl Acad Sci U S A 111:9983-8
Yee, Sook Wah; Chen, Ligong; Giacomini, Kathleen M (2012) The role of ATM in response to metformin treatment and activation of AMPK. Nat Genet 44:359-60
Minematsu, Tsuyoshi; Giacomini, Kathleen M (2011) Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins. Mol Cancer Ther 10:531-9
Li, Shuanglian; Chen, Ying; Zhang, Shuzhong et al. (2011) Role of organic cation transporter 1, OCT1 in the pharmacokinetics and toxicity of cis-diammine(pyridine)chloroplatinum(II) and oxaliplatin in mice. Pharm Res 28:610-25
Choi, J H; Yee, S W; Ramirez, A H et al. (2011) A common 5'-UTR variant in MATE2-K is associated with poor response to metformin. Clin Pharmacol Ther 90:674-84
More, Swati S; Itsara, Melissa; Yang, Xiaodong et al. (2011) Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems. Clin Cancer Res 17:2339-49
Kido, Yasuto; Matsson, Pär; Giacomini, Kathleen M (2011) Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem 54:4548-58
More, Swati S; Akil, Omar; Ianculescu, Alexandra G et al. (2010) Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci 30:9500-9
Ianculescu, Alexandra G; Friesema, Edith C H; Visser, Theo J et al. (2010) Transport of thyroid hormones is selectively inhibited by 3-iodothyronamine. Mol Biosyst 6:1403-10
Chen, Ligong; Takizawa, Miho; Chen, Eugene et al. (2010) Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function. J Pharmacol Exp Ther 335:42-50

Showing the most recent 10 out of 70 publications